|Other names||17α-Demethylstanozolol 17β-tetrahydropyran ether; 17β-[(Tetrahydro-2H-pyran-2-yl)oxy]-5α-androst-2-eno[3,2-c]pyrazole; [3,2-c]Pyrazole-5α-etioallocholane-17β-tetrahydropyranol; 17β-[(Tetrahydro-2H-pyran-2-yl)oxy]-2'H-5α-androst-2-eno[3,2-'c]pyrazole; Pyrazolo[4',3':2,3]-5α-androstan-17β-ol 17β-tetrahydropyran ether|
|Drug class||Androgen; Anabolic steroid; Androgen ether|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||398.591 g·mol−1|
|3D model (JSmol)|
Prostanozol, also known as demethylstanozolol tetrahydropyran ether, is an androgen/anabolic steroid (AAS) and designer steroid which acts as a prodrug of the 17α-demethylated analogue of stanozolol (Winstrol). It was found in 2005 as an ingredient of products sold as "dietary supplements" for bodybuilding.
It is one of hundreds of drugs banned from the Olympics by the IOC. Russian marathon runner Lyubov Denisova was banned for two years from competition after testing positive for prostanozol and testosterone in 2007.
- Eenoo PV, Delbeke FT (2006). "Metabolism and excretion of anabolic steroids in doping control—New steroids and new insights". Journal of Steroid Biochemistry and Molecular Biology. 101 (4–5): 161–178. doi:10.1016/j.jsbmb.2006.06.024. PMID 17000101. S2CID 33621513.
- "192 Banned Performance Enhancing Substances and Methods". ProCon.org. March 17, 2010. Retrieved July 25, 2015.
- "Russian marathon runner Denisova banned for 2 years for doping". USA Today. May 15, 2007. Retrieved July 25, 2015.
|This article about a steroid is a stub. You can help Wikipedia by expanding it.|
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|